552 related articles for article (PubMed ID: 25316229)
1. Correlation of Th17 cells and CD4⁺CD25⁺ regulatory T cells with clinical parameters in patients with systemic sclerosis.
Jiang N; Li M; Zeng X
Chin Med J (Engl); 2014; 127(20):3557-61. PubMed ID: 25316229
[TBL] [Abstract][Full Text] [Related]
2. Elevated levels of CD4(+)CD25(+)FoxP3(+) T cells in systemic sclerosis patients contribute to the secretion of IL-17 and immunosuppression dysfunction.
Liu X; Gao N; Li M; Xu D; Hou Y; Wang Q; Zhang G; Sun Q; Zhang H; Zeng X
PLoS One; 2013; 8(6):e64531. PubMed ID: 23776439
[TBL] [Abstract][Full Text] [Related]
3. Activated and resting regulatory T cell exhaustion concurs with high levels of interleukin-22 expression in systemic sclerosis lesions.
Mathian A; Parizot C; Dorgham K; Trad S; Arnaud L; Larsen M; Miyara M; Hié M; Piette JC; Frances C; Yssel H; Amoura Z; Gorochov G
Ann Rheum Dis; 2012 Jul; 71(7):1227-34. PubMed ID: 22696687
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of Runx1 and lowered proportion of Foxp3⁺ CD25⁺ CD4⁺ regulatory T cells in systemic sclerosis.
Kataoka H; Yasuda S; Fukaya S; Oku K; Horita T; Atsumi T; Koike T
Mod Rheumatol; 2015 Jan; 25(1):90-5. PubMed ID: 24716598
[TBL] [Abstract][Full Text] [Related]
5. Higher levels of serum interleukin-35 are associated with the severity of pulmonary fibrosis and Th2 responses in patients with systemic sclerosis.
Tang J; Lei L; Pan J; Zhao C; Wen J
Rheumatol Int; 2018 Aug; 38(8):1511-1519. PubMed ID: 29846790
[TBL] [Abstract][Full Text] [Related]
6. Disease Manifestation and Inflammatory Activity as Modulators of Th17/Treg Balance and RORC/FoxP3 Methylation in Systemic Sclerosis.
Almanzar G; Klein M; Schmalzing M; Hilligardt D; El Hajj N; Kneitz H; Wild V; Rosenwald A; Benoit S; Hamm H; Tony HP; Haaf T; Goebeler M; Prelog M
Int Arch Allergy Immunol; 2016; 171(2):141-154. PubMed ID: 27902985
[TBL] [Abstract][Full Text] [Related]
7. Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis.
Lei L; He ZY; Zhao C; Sun XJ; Zhong XN
Int J Rheum Dis; 2016 Apr; 19(4):392-404. PubMed ID: 25545680
[TBL] [Abstract][Full Text] [Related]
8. Altered Th17 cells and Th17/regulatory T-cell ratios indicate the subsequent conversion from undifferentiated connective tissue disease to definitive systemic autoimmune disorders.
Szodoray P; Nakken B; Barath S; Csipo I; Nagy G; El-Hage F; Osnes LT; Szegedi G; Bodolay E
Hum Immunol; 2013 Dec; 74(12):1510-8. PubMed ID: 23974054
[TBL] [Abstract][Full Text] [Related]
9. Regulatory T cells (CD4(+)CD25(bright)FoxP3(+)) expansion in systemic sclerosis correlates with disease activity and severity.
Slobodin G; Ahmad MS; Rosner I; Peri R; Rozenbaum M; Kessel A; Toubi E; Odeh M
Cell Immunol; 2010; 261(2):77-80. PubMed ID: 20096404
[TBL] [Abstract][Full Text] [Related]
10. Alteration of Th17 and Treg cell subpopulations co-exist in patients affected with systemic sclerosis.
Fenoglio D; Battaglia F; Parodi A; Stringara S; Negrini S; Panico N; Rizzi M; Kalli F; Conteduca G; Ghio M; De Palma R; Indiveri F; Filaci G
Clin Immunol; 2011 Jun; 139(3):249-57. PubMed ID: 21419712
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-17 and interleukin-23: importance in the pathogenesis of lung impairment in patients with systemic sclerosis.
Olewicz-Gawlik A; Danczak-Pazdrowska A; Kuznar-Kaminska B; Gornowicz-Porowska J; Katulska K; Trzybulska D; Batura-Gabryel H; Silny W; Poplawski D; Hrycaj P
Int J Rheum Dis; 2014 Jul; 17(6):664-70. PubMed ID: 24467649
[TBL] [Abstract][Full Text] [Related]
12. DNA hypermethylation of the forkhead box protein 3 (FOXP3) promoter in CD4+ T cells of patients with systemic sclerosis.
Wang YY; Wang Q; Sun XH; Liu RZ; Shu Y; Kanekura T; Huang JH; Li YP; Wang JC; Zhao M; Lu QJ; Xiao R
Br J Dermatol; 2014 Jul; 171(1):39-47. PubMed ID: 24641670
[TBL] [Abstract][Full Text] [Related]
13. Effects of thalidomide on Th17, Treg cells and TGF-β1/Smad3 pathway in a mouse model of systemic sclerosis.
Lu Y; Zhao C; Lei L; Tao Z; Zheng L; Wen J; Li X
Int J Rheum Dis; 2020 Mar; 23(3):406-419. PubMed ID: 31840939
[TBL] [Abstract][Full Text] [Related]
14. Role of cellular immunity in systemic sclerosis pathogenesis: update on CD4+T cells population studies.
Beşliu AN; Bănică LM; Lonescu R; Predeţeanu D; Stăvaru C; Marica CM; Chiţonu C; Pistol G; Stefănescu M; Matache C
Roum Arch Microbiol Immunol; 2009; 68(1):5-13. PubMed ID: 19507621
[TBL] [Abstract][Full Text] [Related]
15. Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin.
Bovenschen HJ; van de Kerkhof PC; van Erp PE; Woestenenk R; Joosten I; Koenen HJ
J Invest Dermatol; 2011 Sep; 131(9):1853-60. PubMed ID: 21654831
[TBL] [Abstract][Full Text] [Related]
16. Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGFbeta expression.
Radstake TR; van Bon L; Broen J; Wenink M; Santegoets K; Deng Y; Hussaini A; Simms R; Cruikshank WW; Lafyatis R
PLoS One; 2009 Jun; 4(6):e5981. PubMed ID: 19543397
[TBL] [Abstract][Full Text] [Related]
17. Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea.
Antiga E; Quaglino P; Bellandi S; Volpi W; Del Bianco E; Comessatti A; Osella-Abate S; De Simone C; Marzano A; Bernengo MG; Fabbri P; Caproni M
Br J Dermatol; 2010 May; 162(5):1056-63. PubMed ID: 20105169
[TBL] [Abstract][Full Text] [Related]
18. Reduction of regulatory T cells in skin lesions but not in peripheral blood of patients with systemic scleroderma.
Klein S; Kretz CC; Ruland V; Stumpf C; Haust M; Hartschuh W; Hartmann M; Enk A; Suri-Payer E; Oberle N; Krammer PH; Kuhn A
Ann Rheum Dis; 2011 Aug; 70(8):1475-81. PubMed ID: 21097800
[TBL] [Abstract][Full Text] [Related]
19. New insights into CD4(+) T cell abnormalities in systemic sclerosis.
Liu M; Wu W; Sun X; Yang J; Xu J; Fu W; Li M
Cytokine Growth Factor Rev; 2016 Apr; 28():31-6. PubMed ID: 26724976
[TBL] [Abstract][Full Text] [Related]
20. Treg depletion attenuates irradiation-induced pulmonary fibrosis by reducing fibrocyte accumulation, inducing Th17 response, and shifting IFN-γ, IL-12/IL-4, IL-5 balance.
Xiong S; Guo R; Yang Z; Xu L; Du L; Li R; Xiao F; Wang Q; Zhu M; Pan X
Immunobiology; 2015 Nov; 220(11):1284-91. PubMed ID: 26224246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
